NCT01759732View on ClinicalTrials.gov

Haploidentical Stem Cell Transplantation for Children With Acquired Severe Aplastic Anemia

PHASE2UnknownINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2015

Conditions
Acquired Aplastic Anemia
Interventions
DRUG

Fludarabine

40mg/M2 once daily IV on days -7 to -4

DRUG

Cyclophosphamide

60 mg/kg IV on day-3 and -2

BIOLOGICAL

anti-thymocyte globulin

BIOLOGICAL

filgrastim

RADIATION

Total body irradiation

200 cGy per day on D-5 \& -4

PROCEDURE

CD3-depleted hematopoietic cell transplantation

Immunogenetic depletion on CliniMACS

Trial Locations (1)

138-736

RECRUITING

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT01759732 - Haploidentical Stem Cell Transplantation for Children With Acquired Severe Aplastic Anemia | Biotech Hunter | Biotech Hunter